Tissue therapies posts small loss
By Renate Krelle
Thursday, 10 February, 2005
Thursday, 10 February, 2005
Tissue Therapies Limited (ASX:TIS) has released its half-year results, recording a net loss of $445,400, in line with budget expectations.
At December 31, the company had cash reserves of almost $4 million, bolstered by a $1.5 million capital raising in October last year.
It spent $524,000 on research and development, and banked revenue of $152,5000 from research grants and interest.
Related News
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
